A mouse monoclonal antibody, G92. 
A group of transamidating enzymes [EC 2.3.2.13], commonly referred to as transglutaminases (TGases) (1, 2) , have drawn increasing' interest in recent years because of their involvement in a great variety of post-translational events. Most notable is the crosslinking of protein units by N8-(y-glutamyl)lysine bridges. TGases show exquisite specificities in vivo not only for selecting their protein targets but also for the glutamine and lysine sites that participate as partners in the enzyme-driven crosslinking event (3, 4) . Crosslinking can occur by the direct polymerization of protein substrates in the soluble phase, as in the clotting of seminal vesicle secretion proteins in rodents (5) , in the coagulation of lobster plasma (6) , or by the fusion of existing noncovalent protein assemblies, as in the stabilization of the human blood clot (7) .
The latent intracellular TGases can be activated by outside stimuli, as exemplified by the effect of thrombin on platelets (8) or epidermal growth factor on epidermal carcinoma (A431) cells (9) , or simply by the elevation of the intracellular concentration of Ca2 , as demonstrated in human red blood cells (10) . In these cells, TGase causes the covalent fusion of membrane-skeletal components by N--(Qy-glutamyl)lysine bonds, leading to an irreversible rigidification of the plasma membrane and fixation of cell shape (11) . A similar event occurs in keratinocytes where the Ca2+ switch for terminal differentiation causes the TGase-dependent generation of the cornified envelope (12) . TGase-mediated crosslinking of proteins, mainly crystallins, also occurs in the Ca2+-enriched lens (13) .
Recently, TGases have been implicated in the process of apoptosis (14) (15) (16) (17) . Although an exact role for the enzyme has not been' established, it has been suggested that crosslinking of membrane and intracellular proteins occurs in the late stages of apoptosis (ref. 14; for review, see refs. 18 and 19) . Increase in the activity of the tissue form of TGases seems to be associated with a variety of phenomena in a wide range of cell types. These include changes in cellular morphology (20, 21) , growth arrest (22) (23) (24) , terminal differentiation (22) , and increases in adhesion (20, 22) . Analysis of the subcelfular distributions of TGase may reveal clues regarding their mechanisms of action. In this report we show that a high-affin'ity monoclonal antibody to solid-phase guinea pig liver and human red blood cell TGase recognizes a TGase or some TGase-related antigen (TRA) that colocalizes with vimentin intermediate filaments (IFs) in primary mouse dermal fibroblasts.
MATERIALS AND METHODS Antibodies. Purified guinea pig liver TGase (25, 26) was, used as antigen to raise'rabbit polyclonal antibodies and hybridomas in mice. Hybridoma line G92 was positive for the antigen described in this report and was subcloned twice, yielding antibody G92.1.2. IgGs were purified from' tissue culture medium by using a GammaBind Plus Sepharose column (GammaBind G, type 3 ligand; Pharmacia). Polyclonal rabbit antibodies against bovine tongue keratins and baby hamster kidney cell vimentin were prepared as described (27, 28 (29) . Dlermal fibroblast cultures were generated by incubating dermal fragmentg in modified Eagle's medium (MEM; GIBCO/BRL) containing penicillin (50 units/ml), streptomycin (50 ,ug/ml), and type IV collagenase (Sigma; 7.5 mg/ml) in a 370C water bath for 1 h. The digested dermis was filtered through cheese cloth and the cell suspension was washed in MEM containing 10% (vol/vol) fetal bovine serum. The cells were resuspended in the latter medium and were cultured in plastic Petri dishes or on glass coverslips (Bellco Glass, Vineland, NJ). In some experiments, cells'grown on glass coverslips were treated with 7.5 ,ug of colchicine (Sigma) per ml of culture medium. After 7 h, the cells were fixed and processed for double-label indirect immunofluorescence as described below.
ELISA. Purified guinea pig liver TGase (25) , human red blood cell TGase (30) , chicken red blood cell TGase (31) , and recombinant human factor XIII A subunits (32) 
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,ug per well, followed by a wash with the blocking solution of 1% milk in PBS and by addition of alkaline phosphataseconjugated antibody against mouse IgG (Sigma, A-1902; diluted 1:5000). Wells were washed as above and p-nitrophenyl phosphate disodium (Sigma; 1 mg/ml) in 100 mM Tris HCl, pH 9.5/100 mM NaCl/5 mM MgCl2 was added to each well. After 1 h, the color was read in a Dynatech MR600 microplate reader, at 410 nm.
Protein Extracts, Gel Electrophoresis, and Immunoblot Analysis. IF-enriched cell extracts were obtained from cultures of primary mouse dermal fibroblasts (33) . After separation by SDS/PAGE in 6.5% gels (34) , the samples were transferred to nitrocellulose (35) . For immunoblot analysis, rabbit vimentin antiserum was diluted 1:1000 in a 5% (vol/vol) milk/PBS solution, TGase antiserum was diluted 1:5000, and the TGase antibody G92.1.2 was used at 0.34 ,ug/ml. Secondary antibody treatments were carried out with goat anti-rabbit IgG (Jackson ImmunoResearch) or anti-mouse IgG (Kirkegaard & Perry Laboratories) peroxidase-conjugated antibodies (40 ,ug/ml). Binding was detected by either 4-chloro-1-naphthol (Sigma; ref. 36) or by chemiluminescence with an ECL kit (Amersham).
Guinea pig liver homogenate (37) was subjected to SDS/ PAGE in 10% gels and transferred to nitrocellulose (35) . For dot blots, 0.5 jig of the native proteins or their denatured forms (treated with 0.1% SDS and 1 mM dithiothreitol) were spotted onto nitrocellulose. Immunoblot analysis was carried out with TGase antiserum diluted 1:5000 in 1% milk/PBS, or with G92.1.2 at 0.13 ,ug/ml for liver homogenate blots or 2.6 ,ug/ml for dot blots. Secondary antibody treatments were with goat anti-rabbit IgG (Promega) or rabbit anti-mouse IgG (Sigma) alkaline phosphatase-conjugated antibodies (1:5000 dilution). Color was developed with 0.37 mM 5-bromo-4-chloro-3-indolyl phosphate and 0.39 mM nitroblue tetrazolium (Sigma) in 100 mM Tris HCl, pH 9.5/100 mM NaCl/5 mM MgCl2.
Immunofluorescence. Cells grown on glass coverslips were fixed in ice-cold methanol (28) . After fixation, cells were incubated with 100 ,ul of G92.1.2 (85 Ag/ml in PBS), followed by incubation with fluorescein-conjugated goat anti-mouse IgG at 25 ,ug/ml in PBS (Kirkegaard & Perry Laboratories).
For double-label immunofluorescence, the procedure was repeated with antibodies to either vimentin or keratin, and using a rhodamine-conjugated goat anti-rabbit IgG secondary antibody at 25 ,ug/ml in PBS (Jackson ImmunoResearch). Cells were observed and photographed with a Zeiss Axiophot microscope (Zeiss). Confocal microscopy was carried out with a Zeiss Laser Scan Microscope (LSM) equipped with a 488-nm argon and a 543-nm helium-neon laser.
Microinjection. Primary mouse dermal fibroblasts were microinjected with G92.1.2 at 1 mg of IgG per ml of PBS. Thirty minutes after microinjection cells were fixed and stained for immunofluorescence. Microinjections were carried out by using a Zeiss inverted phase-contrast microscope fitted with a Narishige NT-88 hydraulic microinjector-micromanipulator (38 (Fig. 1) . Of the four potential antigens (i.e., human factor XIII A subunits and chicken red blood cell, human red blood cell, and guinea pig liver TGases) plated for ELISA, only the latter two were recognized by G92.1.2 ( Fig. 1) . By dot blot analysis, the antibody was also able to recognize chicken red blood cell TGase (Fig. 1 Inset A, lane 1) . However, when the proteins were denatured by prior treatment with SDS and dithiothreitol, only guinea pig liver and chicken red blood cell TGases were recognized by the antibody in the dot blots (Fig. 1 (28) . Interestingly, the G92.1.2 antibody selectively recognized only a keratin-negative population of cells, indicating that the TRA-positive cells were not keratinocytes (Fig. 2 a and b) . The G92.1.2-specific staining yielded a filamentous pattern (Fig. 2b) (40) . Double-label immunofluorescence with G92.1.2 and vimentin antibodies showed codistribution of the TRA with vimentin IF (Fig. 3) . Precision of the colocalization of the two staining patterns at the level of individual filamentous structures was further demonstrated by confocal microscopy (Fig. 3 c and d) . The (Fig. 4, lane 5) . Mouse NIH 3T3 fibroblasts, which do not express TGase (41) but do express vimentin, could be stained with the antiserum to vimentin but not with G92.1.2 (data not shown).
In primary cultures highly enriched for mouse skin fibroblasts, -73% (n = 500) of the vimentin-positive fibroblasts stained positively with the G92.1.2 antibody. After subculturing, however, the percentage of G92.1.2-positive cells increased to 85% (n = 500). These findings may be related to the observation that TGase activity seems to increase in fibroblasts during the process of assuming a more terminally differentiated or senescent phenotype (23) . TGase activity has also been shown to increase in cells undergoing apoptosis (14, 18, 19) . Since, in general, the survival of most primary cultures diminishes significantly after subculturing (23, 42) (Fig.  4, lane 2) . This shows that the TRA is isolated with the vimentin in the IF-enriched extract. Only a very small portion of the 280-kDa species was present in the soluble fraction after removal of the insoluble material by low-speed centrifugation (data not shown).
The G92.1.2 antibody recognized only the 280-kDa component in Western blots of the whole cell homogenates (Fig. 4,  lane 1) . On the other hand, the polyclonal TGase antiserum stained mainly a band of =116 kDa, while also recognizing the 280-kDa component in whole cell homogenates (Fig. 4, lane 3) . In the IF-enriched fraction, however, this antiserum reacted only with the 280-kDa component (Fig. 4, lane 4) . These results suggest that the TRA associated with the IF network is the 280-kDa component, rather than the soluble, 116-kDa component.
Since the 280-kDa mass of the TRA is close to that of a known fibroblast IFAP, we also examined the possibility that (44), often resulting in the formation of large juxtanuclear caps. We have treated primary mouse fibroblasts with colchicine (7.5 jig/ml) for 7 h prior to processing for double-label immunofluorescence. As shown in Fig. 5 a and (Fig. 6a) . Approximately 52% of injected cells (n = 98) appeared as in Fig. 6a , while the others showed various degrees of responsiveness to the antibody. Further examination showed that the injected G92.1.2 became attached to sites identified by the vimentin antibody ( Fig. 6 a and b) . In fact, injection of the antibody to TGase caused a collapse of the majority of vimentin into perinuclear bundles (Fig. 6b) . This finding further underscores the close association of TRA with vimentin. Throughout this report, the entity recognized by the G92.1.2 antibody was referred to as TRA. However, the possibility must be considered that the TRA may actually represent an as yet unrecognized form among the growing number of intracellular TGases. A key issue in this regard will be to examine whether the protein shows catalytic potential for transamidating activity. Most of the zymogens, or latent enzyme precursors, isolated in this group contain units near or below 100 kDa in mass, as measured by SDS/PAGE. Even the -116-kDa protein, identified with the aid of the polyclonal antiserum as a cytoplasmic TGase in the dermal fibroblast extract (Fig. 4,  lane 3) , exceeds the usual limits of size encountered thus far. The 280-kDa IF-associated TRA may be an oligomeric precursor composed of subunits so tightly bound to each other or to some carrier that conventional treatment for SDS/PAGE does not dissociate them. Regardless of whether the 280-kDa structure is an oligomeric assembly or a TGase precursor covalently attached to some carrier protein, in a fashion similar to that seen for factor XIII, proteolytic processing may be required to generate transamidating activity (45) (46) (47) . A TGase precursor isolated from keratinocytes was also shown to become activated by limited proteolysis (48, 49) .
It is also possible tha,t a domain in the 280-kDa structure has a significant sequence similarity with the TGase epitope recognized by the G92. Cell Biology: Trejo-Skalli et aL rat liver with al-adrenergic receptor signaling function (Gah) was shown to cross react with antibody to guinea pig liver TGase and to have sequence similarity to the latter (50) . The transamidating function of the protein seems to be switched to that of receptor signaling. The membrane-skeletal protein, band 4.2, of human erythrocytes also contains sequence similarities near the active center region of TGases without, however, containing the catalytically important cysteine residue of the enzyme (51, 52) . No cross-reacting antibodies for the 4.2 protein and TGase have been reported.
The functional roles of TRAs tightly associated with the IF network are yet to be determined. If TRAs can become activated in these cells to express transamidating activity, it is possible that their specific substrates may be found among the constituent components of the IF network itself. In vitro, vimentin was found to serve as a substrate for TGase (data not shown). Cross-linking of keratin IF in epithelial cells of the skin through N--(,y-glutamyl)lysine bridges (53) is known to contribute to the stabilization of the filament network.
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